· · · · · 

This Week in Sex: New Research on Improving Intimacy, and a Kegel Counter That Vibrates

New research suggests that orgasms promote positive pillow talk.

This week, new research suggests that orgasms promote positive pillow talk and improve intimacy but alcohol has the opposite effect; a study finds that the new HIV-prevention drug Truvada may also reduce the risk of genital herpes; and a vibrator company introduced a Fitbit for your vagina.

· · · · · 

What’s Up With Women and HIV-Prevention Method PrEP?

The anti-retroviral drug Truvada, which is a combination of tenofovir and emtricitabine.

PrEP works when used properly. So why don’t women use it?

· · · · · 

The HIV Prevention Pill: How Is Truvada Taking Root in Black Communities?

In the months since the FDA’s approval of Truvada, some who work on prevention efforts in Black and low-income communities have urged PrEP proponents to pump their brakes.

· · · · · 

Sexual Health Roundup: HIV-Prevention Drug Wins FDA Panel Approval, Parents Talk About Internet Pornography

A New York Times article looks at how parents do (and should) react when their children inevitably see Internet pornography, an FDA advisory panel recommends approving a drug for HIV-prevention, and Massachusetts cuts over $1 million from its HIV-prevention and testing program in county jails. 

· · · · · 

Sexual Health Roundup: Promising Advances in HIV Prevention and Treatment; New Evidence on HPV, Cancer, and Vaccines

In this week’s sexual health roundup: scientists use engineered stem-cells to attack HIV; California tests a new pill that prevents HIV infection when taken daily but some question how expensive it is; the CDC releases alarming data on cancers caused by HPV in women; and South Carolina lawmakers take steps to increase HPV vaccination among middle school students.

· · · · ·